Gilead Sciences to Present at the Nasdaq 37th Investor Program on Wednesday, December 6
November 22 2017 - 9:00AM
Business Wire
Webcast Available Through Gilead Corporate
Website
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Kevin
Young CBE, Gilead’s Chief Operating Officer and Andrew Cheng,
Executive Vice President, Clinical Research and Development
Operations, will participate in a fireside chat at the Nasdaq 37th
Investor Program in London on Wednesday, December 6 at 8:15 a.m.
Greenwich Mean Time (3:15 a.m. Eastern Time).
The audio portion of the fireside chat will be accessible live
through the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior
to the start of the presentation to ensure adequate time for any
software download that may be required to listen to the webcast.
The replay will be available for 14 days following the
presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171122005077/en/
Gilead Sciences, Inc.Sung Lee, 650-524-7792Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024